IP Library Granted Patent US 8,728,778
Granted Patent B2
US 8,728,778 · App. 11/924,350 · Granted May 20, 2014

Microbial strains and processes for the manufacture of biomaterials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,778
App. No.
11/924,350
Granted
May 20, 2014
Kind
B2
Abstract

DNA constructs and genetically engineered microbial strains constructed using these DNA constructs, which produce a nuclease enzyme with specificity for DNA and/or RNA, are provided. These strains secrete nuclease into the periplasm or growth medium in an amount effective to enhance productivity and/or recovery of polymer, and are particularly suited for use in high cell density fermentation processes. These constructs are useful for modifying microbial strains to improve production and recovery processes for polymers such as intracellular proteins, such as enzymes, growth factors, and cytokines; for producing polyhydroxyalkanoates; and for producing extracellular polysaccharides, such as xanthan gum, alginates, gellan gum, zooglan, hyaluronic acid and microbial cellulose.

Claims (11)

1. A fermentation process comprising

adding to a growth medium a bacterial strain having a periplasmic space,

wherein the bacteria produce polyhydroxyalkanoates, and

wherein the bacteria express a heterologous nuclease gene or a genetically modified homologous nuclease gene integrated into the bacterial chromosome, the product of which is secreted into the periplasmic space,

mutating the bacterial strain, and

screening for bacteria expressing enhanced nuclease activity in an amount effective to degrade in less than 24 hours at least 95% of all of the nucleic acid released following lysis of bacterial cells in less than 24 hours.

2. The process of claim 1 wherein the bacterial strain is grown to cell densities of at least 50 g/l.

3. The process of claim 1 further comprising growing the bacterial strain to produce levels of at least 40% of its dry cell weight.

4. The process of claim 1 further comprising lysing the cells.

5. The process of claim 3 further comprising using an aqueous process to manufacture a poly(3-hydroxyalkanoates) granule suspension which is essentially free of nucleic acids.

6. The process of claim 1 wherein the nuclease gene is integrated into the chromosome of a host strain selected from the group consisting of Ralstonia eutropha, Methylobacterium organophilum, Methylobacterium extorquens, Aeromonas caviae, Azotobacter vinelandii, Alcaligenes latus, Pseudomonas oleovorans, Pseudomonas fluorescens, Pseudomonas putida, Pseudomonas aeruginosa, Pseudomonas acidophila, Pseudomonas resinovorans, Escherichia coli , and Klebsiella.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: CJ RESEARCH CENTER LLC
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 042522/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2017
From: METABOLIX, INC.
To: CJ RESEARCH CENTER LLC
Reel/Frame 041234/0890 →
ADDRESS CHANGE Recorded May 2, 2016
From: METABOLIX, INC.
To: METABOLIX, INC.
Reel/Frame 038665/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2007
From: HUISMAN, GJALT W.; LUO, LAURA ZHUANG; HOROWITZ, DANIEL M.; GERNGROSS, TILLMAN U.; PEOPLES, OLIVER P.
To: METABOLIX, INC.
Reel/Frame 020170/0085 →